Much, if not all of the biologic activity of polycyclic aromatic hydrocarbons and related pollutants (e.g. TCDD) is mediated by the aryl hydrocarbon receptor (AhR). AhR activation is associated with production of reactive metabolites, induction of proto-oncogenes, activation of transcription factors (including NF-kB), and aberrant cell function. In general, the AhR is positioned at the apex of a network of intracellular interactions which could contribute significantly to malignant transformation through multiple mechanisms. In particular, a number of recent observations suggest that the AhR is involved in regulating cell growth: (1) high level AhR expression in rodent and human tumors; (2) physical association of the AhR with RelA, an NF-kB family member; (3) up-regulation of the c-myc promoter after AhR and Re/A gene transfection; and 4) inhibition of mammary tumor cell growth with AhR antagonists and an inducible AhR antisense. From these and other results, it is hypothesized that AhR expression predisposes mammary tissue to PAH-mediated transformation and that high levels of potentially active AhR directly influence epithelial cell growth or function.
Three specific aims have been defined to test these hypotheses: (1) Evaluate AhR hyper-expression and activation during rat mammary gland tumorigenesis. These studies will determine if changes in AhR expression or function precede or coincide with malignant transformation and will provide information critical to construction of an accurate model of mammary epithelial cell transformation; (2) Generate transgenic mice in which high level AhR expression is directed toward mammary tissue. These studies will test if high level AhR expression in mammary tissue accelerates transformation and will result in the production of small animal models in which molecular mechanisms of transformation can be dissected; and (3) Determine AhR function in pre-malignant and malignant human breast cancer cell lines. In addition to extending results to human systems, these studies will elucidate molecular mechanisms through which the AhR is postulated to influence cell growth or function. Proposed studies will directly address the potential role of the AhR in mammary tumorigenesis in the presence and the absence of environmental PAH.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Program Projects (P01)
Project #
1P01ES011624-01
Application #
6544411
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2001-09-30
Project End
2006-07-31
Budget Start
Budget End
Support Year
1
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Boston University
Department
Type
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Smith, Brenden W; Stanford, Elizabeth A; Sherr, David H et al. (2016) Genome Editing of the CYP1A1 Locus in iPSCs as a Platform to Map AHR Expression throughout Human Development. Stem Cells Int 2016:2574152
Das, Sonia G; Romagnoli, Mathilde; Mineva, Nora D et al. (2016) miR-720 is a downstream target of an ADAM8-induced ERK signaling cascade that promotes the migratory and invasive phenotype of triple-negative breast cancer cells. Breast Cancer Res 18:40
Stanford, Elizabeth A; Wang, Zhongyan; Novikov, Olga et al. (2016) The role of the aryl hydrocarbon receptor in the development of cells with the molecular and functional characteristics of cancer stem-like cells. BMC Biol 14:20
Romagnoli, Mathilde; Mineva, Nora D; Polmear, Michael et al. (2014) ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis. EMBO Mol Med 6:278-94
Sherr, David H; Monti, Stefano (2013) The role of the aryl hydrocarbon receptor in normal and malignant B cell development. Semin Immunopathol 35:705-16
Mineva, Nora D; Paulson, K Eric; Naber, Stephen P et al. (2013) Epigallocatechin-3-gallate inhibits stem-like inflammatory breast cancer cells. PLoS One 8:e73464
Sato, Seiichi; Zhao, Yingshe; Imai, Misa et al. (2013) Inhibition of CIN85-mediated invasion by a novel SH3 domain binding motif in the lysyl oxidase propeptide. PLoS One 8:e77288
Smith, Brenden W; Rozelle, Sarah S; Leung, Amy et al. (2013) The aryl hydrocarbon receptor directs hematopoietic progenitor cell expansion and differentiation. Blood 122:376-85
Quintana, Francisco J; Sherr, David H (2013) Aryl hydrocarbon receptor control of adaptive immunity. Pharmacol Rev 65:1148-61
Iskratsch, Thomas; Reijntjes, Susan; Dwyer, Joseph et al. (2013) Two distinct phosphorylation events govern the function of muscle FHOD3. Cell Mol Life Sci 70:893-908

Showing the most recent 10 out of 66 publications